reiter buy ci post strong result mark sizabl beat
strength across busi line better mcr lower expect medic
cost trend strong cf rais guidanc addit remain bullish
pend esrx deal view benefit combo appreci
think esrx print suggest strong momentum rais
estim up target vs reflect new estim
increas convict around esrx deal view merger relat
concern misplac valuat risk/reward compel
impress result across board mark stronger top-lin better
expect mcr adjust ep well ahead strhe
consensu ci valu driven servic base model continu
reson industri lead medic cost trend guid lower
strength seen across busi line global health
global supp group disabl life grew adjust incom
oper respect addit cash flow remain
strong financi flexibl high compani rais guidanc full-year
guidanc increas driven
global supp full-year commerci govern mcr
think quit bit remain bullish pend esrx deal esrx
buy see power opportun combin entiti across
broad rang area view concern around combin creat
meaning opportun compel valuat risk/reward highlight
thought view topic issu surround
rebat past sever month pbm sector seen uptick
volatil tie view overblown concern around area rebates/
contract structur highlight esrx releas current pass
pharma purchas discount price reduct rebat
core pbm commerci health plan custom
rebat given question receiv around rebat potenti go away
thought highlight salient point acknowledg
contract like continu evolv time rebat go
away vacuum without commensur price chang result
tr target
would explod cost client patient go happen given signific portion
benefit pass addit would highlight much like ci client esrx
custom fund option almost half chosen direct pass-through contract rebat
expect area contract evolv view recent concern overblown view
contract tie outcom area like see increas traction time one
think would leav combin ci/esrx extrem well posit
sustain anoth topic recent discuss around busi sustain esrx
would highlight two differ point custom competit think relev
allay concern pbm industri highli competit decad domin
three scale sophist player express script caremark optumrx
buy buy combin process adjust claim think
competit dynam three saw pocket earn would
short live industri particip would come competit shut light via
share gain rather quickli addit esrx servic mani sophist purchas
healthcar includ govern countri compani product competit
touch highlight strong retent rate impress drug trend increas penetr
servic view highli sustain
suggest product offer reson market build momentum
compani rais retent rate guidanc rang prior
expect core busi adjust claim growth best core number year
importantli client adopt compani new solut specialti safeguardrx advanc
util manag program advanc opioid manag run ahead
would highlight much like ci esrx client see notic impact trend
penetr compani solut trend solut util solut
solut ytd esrx client achiev record low drug trend
impress combin clinic horsepow ci current clinician esrx employ
addit integr medic pharmaci benefit think combin
provid increas clinic differenti especi care patient highli complex
costli condit esrx resourc center trc special train pharmacists/
nurses/staff diseas specif expertis across broad rang complex diseas categori
key offer within accredo help compani close gap care increas adher
drive improv clinic outcom cost-effect way trc also repres
anoth touch point chronic higher cost patient provid data million clinic
interact annual help provid action intellig express script safeguardrx
program help client improv access afford high cost drug across broad rang
diseas categori oncolog inflammatori condit diabet cholesterol hep
safeguardrx program help focu valu align cost outcom provid variou
differ cost benefits/discount reimburs earli drug discontinu protect
client outsiz brand drug price increas inflat protect program evicor
current custom round intern clinic offer provid integr
program focus complex diseas condit provid combin compani
addit tool drive deeper collabor penetr valu base care
free least combin focu least view ci esrx
capit effici compani gener signific free cash flow manag continu
project combin compani gener least free cash flow look
quit doabl us combin compani robust expect free cash flow allow rapid de-
lever provid financi firepow on-going capit deploy augment core trend
posit global health busi post anoth stronger quarter mark
page
adjust incom oper growth tax margin expans vs
commerci govern produc solid medic care ratio
full year mcr guidanc segment improv commerci
govern compani also lower full year expect medic cost trend
govern busi estim assum increment growth view
compani well posit custom plan
global supp group disabl life also parti global supp group
disabl life busi line post solid growth global supp saw full year adjust oper
incom guidanc rais compani saw strong global supp growth across key market
 china korea driven supp china post growth
korea come solid double-digit growth addit quarter compani
sign definit agreement acquir onepath life nz anz bank new zealand largest
bank new zealand deal expect close earli includ strateg allianc
meaning increas compani presenc countri expect ci continu
focu opportun expand product line distribut capabl group
disabl life post adjust oper incom growth grew adjust after-tax margin
y/i tie solid result disabl favor trend life
strong attract flexibl compani continu gener
attract like capit effici busi model financi flexibl high debt-to-cap
stand expect combin ci/esrx power cash flow gener
allow rapid de-lever increment capit deploy opportun end
parent cash capit avail deploy
opportun rais ep
reflect result updat guidanc also rais price target ep
reflect superb underli trend impress cost manag capabl continu progress
clinic collaboration/valu base care increas convict around pend express script
deal view recent industri nois creat opportun view benefit combin
compani meaning appreci valu risk/reward compel reiter
buy rate
page
mo pharmaci revenu
revenu
revenu
page
global provid health servic three divis global health global
supplement benefit group disabl life global health far largest
revenu offer multitud product across broad rang market person
offer local focu global supplement benefit segment provid supplement health
life accid insur select market group disabl segment
offer disabl group life accid specialti insur product primarili
buy rate ci see signific on-going opportun across busi would expect
compani highli integr value-bas approach continu reson market
look on-going share gain addit think strategic/financi benefit around pend
esrx deal underappreci view valuat risk/reward compel
valuat risk
trade ep meaning discount manag care group averag tie
larg view appreci valu pend acquisit esrx like
compani integr offer attract absolute/rel medic trend strong cash flow see
meaning opportun sever front pend express script combin
price target base ci trade ep premium current multipl still discount
peer group averag risk includ meaning exposur commerci market
view less attract growth prospect vs govern pay sizabl pend esrx
bring integr risk
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
